ArticleNational science review2025
Halogenated diphenyl ether solvent additives enable ∼20% efficiency organic solar cells and high-performance opaque/semitransparent modules.
Article in National science review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Precise End-Group Conjugated-Site Isomerization of Wing-Typed Dimeric Acceptors Enables 20.32% Efficiency Organic Solar Cells.Angewandte Chemie (International ed. in English) · 2026Article
- Chalcogen heteroatom engineering of solid additives with optimized excited-state properties enables the development of high-performance organic solar cells.Chemical science · 2026Article
- Electrostatic Potential Tuning by Low-Volatility Halogenated Additive: Boosting PTQ10-Based Binary OPV to Near 20% Efficiency with High Scalability.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Droplet-Merging and Dissolution-Induced Intermediate State Strategy Enabled Efficiency > 17.5% for the Printed Organic Solar Cells.Nano-micro letters · 2026Article
- Rational Asymmetric Acceptor Engineering via Unidirectional Terminal π-Extension and Optimizing Alkyl Branching Sites Affords a Binary Photovoltaic Efficiency of 20.7% by Suppressed Nonradiative Energy Loss.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Conformational entropy tuning in nonfused-ring electron acceptors for low-cost and record-efficiency organic solar cells.National science review · 2026Article
- Polyfluorophenyl quinoxaline derived acceptors with long exciton diffusion length for efficient thin-film/thick-film organic solar cells.Nature communications · 2026Article
- Resolving Ternary Morphology for High-Performance Thickness-Insensitive Organic Solar Cells.ACS applied materials & interfaces · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solvent additives are considered as versatile tools to optimize morphology for boosting power conversion efficiency (PCE) of organic solar cells (OSCs). Here, three halogenated diphenyl ether (DPE) solvent additives (fluorinated DPE-F, chlorinated DPE-Cl and brominated DPE-Br) are developed to optimize active-layer (PM6:L8-BO) morphology. With the halogen atomic weight increases, three additives show a gradually increasing boiling point, while DPE-Cl and DPE-Br have similar but a much higher dipole moment compared to DPE-F. The higher boiling point and dipole moment of DPE-Br are expected to enhance the non-covalent interaction between the additive and L8-BO during the active layer film-forming process, offering improved intermolecular packing, charge transport, exciton dissociation and charge collection. As a result, the DPE-Br-treated OSC achieves a higher PCE (18.40%) compared to the DPE-F- and DPE-Cl-treated ones (17.73% and 18.03%). Impressively, using D18 as the donor, the OSCs based on DPE-Br-processed D18:L8-BO:BTP-eC9 obtain a further boosted PCE of ∼20%, while their 11.6 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.